Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome
Clicks: 452
ID: 119028
2017
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.4
/100
452 views
50 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #14 of 292 articles by views in Proceedings of the National Academy of Sciences of the United States of America
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 292 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Polycystic ovary syndrome (PCOS) is a complex hormonal disorder characterized by reproductive, endocrine, and metabolic abnormalities. As the origins of PCOS remain unknown, mechanism-based treatments are not feasible and current management relies on treatment of symptoms. Hyperandrogenism is the mo …
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (40 words).
Try re-searching for a better abstract.
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.